Determination of plasma prothrombin with a reaction rate analyzer using a synthetic substrate.

作者: Kurt Bergström , Margareta Blombäck

DOI: 10.1016/0049-3848(74)90016-4

关键词: Substrate (chemistry)ThrombinReaction rateReagentCoagulationDicoumarolTripeptideAnalytical chemistryChromogenicChemistryChromatography

摘要: Abstract The conventional clotting methods for determination of plasma prothrombin all involve fibrinogen-fibrin conversion as an indicator thrombin activity. This is a complex reaction and preliminary attempts to follow the initial polymerization by rate analyzer (LKB 8600) were abandoned. It was more appropriate use synthetic chromogenic substrate (1). generated allowed split tripeptide yielding p-nitroaniline, liberation which followed in analyzer. In order convert we used reagent containing partially purified coagulation factors first phase. Other commercial reagents did not function this system. results are agreement with determinations normal individuals dicoumarol treated patients. Obvious advantages method attractive kinetic way assaying prothrombin. mechanized system gives better reproducibility saves manual work.

参考文章(11)
K.W. Denson, The specific assay of Prower-Stuart factor and factor VII. Acta Haematologica. ,vol. 25, pp. 105- 120 ,(1961) , 10.1159/000206523
Ingrid Norén, Specific assay of prothrombin. A method using a freeze-dried reagent of intrinsic coagulation factors. Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 25, pp. 47- 58 ,(1970) , 10.3109/00365517009046189
I. NOREN, E. CARLSSON, G. KRETZSCHMAR, A.-C. TEGER-NILSSON, Prothrombin in newborns and during the first year of life. Acta Paediatrica. ,vol. 60, pp. 269- 277 ,(1971) , 10.1111/J.1651-2227.1971.TB06656.X
Lars Svendsen, Birger Blombäck, Margareta Blombäck, Per I. Olsson, Synthetic chromogenic substrates for determination of trypsin, thrombin and thrombin-like enzymes Thrombosis Research. ,vol. 1, pp. 267- 278 ,(1972) , 10.1016/0049-3848(72)90023-0
Ingrid Norén, Margareta Blombäck, Specific determinations of prothrombin during anticoagulant treatment. Acta Medica Scandinavica. ,vol. 192, pp. 77- 83 ,(2009) , 10.1111/J.0954-6820.1972.TB04781.X
M. Eric Gershwin, James K. Gude, Deep Vein Thrombosis and Pulmonary Embolism in Congenital Factor VII Deficiency New England Journal of Medicine. ,vol. 288, pp. 141- 142 ,(1973) , 10.1056/NEJM197301182880309
J. Hellemans, M. Vorlat, M. Verstraete, SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES. British Journal of Haematology. ,vol. 9, pp. 506- 512 ,(1963) , 10.1111/J.1365-2141.1963.TB05475.X
Inga Marie Nilsson, Margareta Blombäck, Olof Ramgren, Haemophilia in Sweden. VI. Treatment of haemophilia A with the human antihaemophilic factor preparation (fraction I--0). Acta Medica Scandinavica. ,vol. 171, pp. 61- 110 ,(2009) , 10.1111/J.0954-6820.1962.TB18848.X
Ingrid Norén, Rapid Tests for Coagulation Disorders Karger Publishers. ,vol. 38, pp. 690- 695 ,(1972) , 10.1159/000427502
Ingrid Norén, Margareta Blombäck, Specific determinations of prothrombin for evaluation of liver function. Acta Medica Scandinavica. ,vol. 191, pp. 257- 262 ,(1972) , 10.1111/J.1365-2796.1972.TB00048.X